CSPC Pharmaceutical Group (HKG:1093) plans to further buy back shares on the market for up to HK$5 billion including the buyback plan of HK$1 billion approved earlier.
The company has already utilized HK$773 million of the HK$1 billion buyback plan to repurchase 163,860,000 shares as of Thursday, a same-day filing with the Hong Kong Exchange said.
The bought-back shares will be cancelled, the disclosure said.
CSPC Pharmaceutical Group had already repurchased shares for HK$387 million in the first half of this year.
Shares of the company rose 1% at close of Thursday trade.
Price (HKD): $4.69, Change: $+0.040, Percent Change: +0.86%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.